| 1 |
34890285 | Synergistic inhibitory effects of 5-aza-2'-deoxycytidine and cisplatin on urothelial carcinoma growth via suppression of TGFBI-MAPK signaling pathways. | 2022 Apr |
1 |
| 2 |
29456534 | Critical Role of TGF-β and IL-2 Receptor Signaling in Foxp3 Induction by an Inhibitor of DNA Methylation. | 2018 |
2 |
| 3 |
29555582 | Suberanilohydroxamic acid prevents TGF-β1-induced COX-2 repression in human lung fibroblasts post-transcriptionally by TIA-1 downregulation. | 2018 May |
2 |
| 4 |
29843383 | CRISPR-Mediated Reactivation of DKK3 Expression Attenuates TGF-β Signaling in Prostate Cancer. | 2018 May 28 |
1 |
| 5 |
28405157 | Decitabine reverses TGF-β1-induced epithelial-mesenchymal transition in non-small-cell lung cancer by regulating miR-200/ZEB axis. | 2017 |
3 |
| 6 |
28435228 | Erratum: Decitabine reverses TGF-β1-induced epithelial-mesenchymal transition in non-small-cell lung cancer by regulating miR-200/ZEB axis [Corrigendum]. | 2017 |
1 |
| 7 |
28802229 | TGF-β-mediated repression of MST1 by DNMT1 promotes glioma malignancy. | 2017 Oct |
1 |
| 8 |
25502084 | The downregulation of miR-200c/141 promotes ZEB1/2 expression and gastric cancer progression. | 2015 Jan |
2 |
| 9 |
25003579 | Decitabine reactivated pathways in platinum resistant ovarian cancer. | 2014 Jun 15 |
1 |
| 10 |
25860431 | The Expression of DNMT1 in Pathologic Scar Fibroblasts and the Effect of 5-aza-2-Deoxycytidine on Cytokines of Pathologic Scar Fibroblasts. | 2014 May |
1 |
| 11 |
24228511 | [Effect of the methylation enzyme inhibitors of 5-aza-2-deoxycytidine on the TGF-beta/smad signal transduction pathway in human keloid fibroblasts]. | 2013 Jul |
3 |
| 12 |
18292494 | Cutting edge: TGF-beta-induced expression of Foxp3 in T cells is mediated through inactivation of ERK. | 2008 Mar 1 |
1 |
| 13 |
15905358 | Insensitivity to transforming growth factor-beta results from promoter methylation of cognate receptors in human prostate cancer cells (LNCaP). | 2005 Sep |
2 |
| 14 |
9632722 | Induction of transforming growth factor-beta receptor type II expression in estrogen receptor-positive breast cancer cells through SP1 activation by 5-aza-2'-deoxycytidine. | 1998 Jun 26 |
2 |